Xilio Therapeutics, Inc. logo XLO - Xilio Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 3
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $98.00 DETAILS
HIGH: $98.00
LOW: $98.00
MEDIAN: $98.00
CONSENSUS: $98.00
UPSIDE: 1087.88%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Revenue
Revenue 12.6 13.7 19.1 8.1 2.9 1.7 2.3 2.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 0.3 0 0 15.3 0 0 0 0 0 0.4 0 0.5 0 0 0 0 0 0 0 0 0 0 0 0 0.1
Gross Profit 12.3 13.7 19.1 (7.2) 2.9 1.7 2.3 2.4 0 (0.4) 0 (0.5) 0 0 0 0 0 0 0 0 0 0 0 0 (0.1)
Operating Expenses
R&D Expenses 19.8 18.1 14.3 15.3 8.3 8.8 10.8 11.2 10.4 11.7 11.1 13.2 16.1 15.0 13.0 16.2 14.9 11.4 10.5 17.7 11.6 17.7 11.5 9.1 5.6
SG&A Expenses 6.6 7.4 6.7 7.1 8.5 6.5 6.3 5.8 6.1 5.9 6.3 6.4 7.4 8.2 7.2 8.3 6.3 8.2 5.5 5.3 4.9 2.9 3.2 2.3 2.1
Other Expenses 0 0 0 (15.3) 0 0 (0.0) 0.0 0.9 0 0 0 0 0 0 0.0 0 0 0 0 0 0 0 0 0
Operating Expenses 26.4 25.5 21.0 7.1 16.8 15.4 17.0 17.1 17.5 17.7 17.4 19.6 23.5 23.2 20.2 24.6 21.2 19.6 16.0 23.0 16.5 20.6 14.6 11.4 7.8
Operating Income
Operating Income (14.1) (11.8) (1.9) (14.4) (13.9) (13.6) (14.8) (14.7) (17.5) (18.1) (17.4) (20.1) (23.5) (23.2) (20.2) (24.6) (21.2) (19.6) (16.0) (23.0) (16.5) (20.6) (14.6) (11.4) (7.9)
Interest Expense 0 0 0 0 0 0 0 0 0 0.1 0.2 0.2 0 0 0 0 0.1 0 0 0 0 0 0 0 0
Interest Income 0 0 0 0 0 0 0 0 0 0.1 0 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0
Profitability
EBITDA (13.8) (11.5) (1.6) (14.0) (13.4) (13.3) (14.4) (14.2) (16.1) (17.1) (16.9) (18.7) (23.0) (22.7) (19.7) (24.1) (20.8) (19.2) (15.6) (22.6) (16.2) (20.3) (14.3) (11.2) (8.0)
EBIT (14.1) (11.8) (1.9) (14.4) (13.9) (13.6) (14.8) (14.7) (16.5) (17.6) (17.4) (19.2) (23.5) (23.2) (20.2) (24.6) (21.2) (19.6) (16.0) (23.0) (16.5) (20.6) (14.6) (11.4) (8.1)
Income Before Tax (9.5) 10.4 (16.3) (15.8) (13.3) (13.1) (14.0) (13.9) (17.2) (17.7) (16.7) (19.4) (22.6) (22.5) (19.8) (24.6) (21.4) (19.7) (16.3) (23.2) (16.7) (20.8) (14.8) (11.5) (8.1)
Income Tax Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (9.5) 10.4 (16.3) (15.8) (13.3) (13.1) (14.0) (13.9) (17.2) (17.7) (16.7) (19.4) (22.6) (22.5) (19.8) (24.6) (21.4) (19.7) (16.3) (23.2) (16.7) (20.8) (14.8) (11.5) (8.1)
Per Share Data
EPS (Basic) -0.58 0.96 -1.54 -4.34 -2.52 -2.80 -3.08 -4.48 -8.68 -8.96 -8.54 -9.80 -11.62 -11.48 -10.08 -12.60 -10.92 -13.72 -297.78 -440.72 -329.42 -440.44 -338.66 -391.72 -277.62
EPS (Diluted) -0.58 0.81 -1.54 -4.34 -2.52 -2.80 -3.08 -4.48 -8.68 -8.96 -8.54 -9.80 -11.62 -11.48 -10.08 -12.60 -10.92 -13.72 -297.78 -440.72 -329.42 -440.44 -338.66 -391.72 -277.62
Shares Outstanding 163.5 83.6 10.3 3.7 5.3 4.6 4.5 3.1 2.0 2.0 2.0 2.0 1.9 2.0 2.0 2.0 2.0 1.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4
Current Assets
Cash & Cash Equivalents 150.3 137.5 103.8 121.6 89.1 55.3 61.3 74.9 34.0 44.7 59.8 75.4 93.3 120.4 139.1 159.4 177.0 198.1 99.8 120.3 141.2 19.2
Short-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Receivables 0 5 0 0 0 0 0 0 30 0 0 0 0 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 3.9 2.5 20.3 2.2 4.1 4.9 2.0 0 5.2 3.4 0 3.0 0 4.1 3.2 0 4.1 4.5 3.4 2.4 0.2 0
Total Current Assets 154.2 145.0 124.1 123.7 93.2 60.2 63.3 78.0 69.2 48.1 64.5 78.4 97.0 124.5 142.3 163.0 181.1 202.5 105.6 124.6 142.6 20.6
Non-Current Assets
Property, Plant & Equipment 7.5 7.9 7.8 8.3 8.7 9.1 9.6 10.0 10.5 11.2 11.6 12.2 12.7 12.8 13.2 13.2 13.4 13.9 13.2 13.4 13.7 14.1
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 1.8 0 1.8 1.8 1.8 1.8 0 2.8 0 0 0 0 1.6 1.6 0 1.6 1.6 0 1.6 1.6 0
Other Non-Current Assets 1.8 0 1.8 0 0 0 0 1.9 0.1 1.6 1.7 1.8 1.8 0.3 0.3 1.9 0.4 0.1 2.0 0.4 0.5 1.7
Total Non-Current Assets 9.3 9.7 9.6 10.1 10.5 10.8 11.3 11.9 13.4 12.8 13.4 13.9 14.5 14.7 15.1 15.1 15.3 19.1 15.2 15.4 15.7 15.7
Total Assets 163.5 154.7 133.7 133.8 103.7 71.1 74.7 89.9 82.6 60.9 77.8 92.4 111.5 139.2 157.4 178.1 196.4 221.6 120.7 140.0 158.3 36.3
Current Liabilities
Account Payables 1.1 3.2 2.3 4.1 2.3 2.6 1.0 1.3 0.7 1.1 1.5 0.9 2.0 3.1 1.8 1.4 2.3 3.1 3.8 8.4 2.6 5.4
Short-Term Debt 1.4 1.3 1.3 0 0 0 0 0 0 3.3 5.0 7.1 6.7 6.7 5.9 3.3 2.5 0.9 0 4.7 4.1 2.3
Deferred Revenue 31.5 40.0 43.8 42.3 40.3 13.5 26.1 0 21.7 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 9.0 11.7 9.0 2.7 1.4 4.2 3.4 26.5 6.7 6.9 0 0.1 0.1 0.1 4.5 0.1 5.1 3.6 0.1 6.2 8.7 0
Total Current Liabilities 43.0 56.3 56.4 53.3 47.6 27.3 38.0 38.6 31.6 16.0 16.9 16.3 16.2 21.1 16.8 17.8 12.2 12.8 12.9 21.3 16.3 22.2
Non-Current Liabilities
Long-Term Debt 5.3 5.6 6.0 0 0 0 0 0 0 0 0 0 1.5 3.2 4.8 6.4 8.0 9.6 9.6 5.5 6.4 7.8
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3.5 0 0 0 0
Other Non-Current Liabilities 42.7 57.5 79.4 38.5 0 0 0 10.3 0 0 0 0.0 0.0 0.0 0.1 0.1 0.1 0 224.4 1.1 1.1 0.5
Total Non-Current Liabilities 48.0 63.1 85.4 73.5 45.4 26.2 15.7 17.8 25.3 8.1 8.4 8.7 10.5 12.4 14.3 16.1 18.0 23.4 244.3 17.1 18.3 19.4
Total Liabilities 90.9 119.4 141.8 126.7 93.0 53.5 53.7 56.5 56.8 24.1 25.3 25.0 26.7 33.5 31.1 33.9 30.2 36.2 257.2 38.4 34.6 41.6
Stockholders' Equity
Common Stock 26.3 36.9 53.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0.0 0.0 0
Retained Earnings (428.3) (418.8) (429.1) (412.9) (397.0) (383.8) (370.7) (356.6) (342.7) (325.5) (307.9) (291.1) (271.8) (249.1) (226.6) (206.9) (182.2) (160.9) (141.2) (124.9) (101.8) (85.1)
Accumulated Other Comprehensive Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Stockholders' Equity 72.5 35.3 (8.1) 7.1 10.7 17.6 21.0 33.4 25.8 36.8 52.5 67.4 84.8 105.6 126.3 144.2 166.1 185.4 (136.5) 101.6 123.8 (5.3)
Total Liabilities & Equity 163.5 154.7 133.7 133.8 103.7 71.1 74.7 89.9 82.6 60.9 77.8 92.4 111.5 139.2 157.4 178.1 196.4 221.6 120.7 140.0 158.3 36.3
Debt Metrics
Total Debt 6.6 7.0 7.3 7.6 7.9 8.1 8.4 8.7 8.9 11.5 14.5 16.8 18.1 19.9 21.0 20.2 21.2 20.7 20.7 20.7 21.2 21.9
Net Debt (143.7) (130.6) (96.5) (114.0) (81.2) (47.1) (52.8) (66.3) (25.0) (33.2) (45.3) (58.6) (75.2) (100.4) (118.2) (139.2) (155.7) (177.3) (79.1) (99.5) (120.0) 2.6
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Operating Activities
Net Income (9.5) 10.4 (16.3) (15.8) (13.3) (13.1) (14.0) (13.9) (17.2) (17.7) (16.7) (19.4) (22.6) (22.5) (19.8) (24.6) (21.4) (19.7) (16.3) (23.2) (16.7) (20.8) (14.8) (0.0) (0.0)
Depreciation & Amortization 0.3 0.3 0.3 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.5 0.5 0.5 0.4 0.4 0.4 0.4 0.4 0.3 0.3 0.3 0.0 0.0
Stock-Based Compensation 0 2.9 0 1.4 1.5 1.5 1.6 1.5 1.8 0 1.9 1.8 1.8 1.8 1.9 2.7 2.0 2.1 1.1 1.0 0.8 0.4 0.7 0.0 0.0
Change in Working Capital (12.1) 5.7 (18.1) (2.7) 40.2 (3.0) (36.3) 31.9 4.4 1.8 1.0 0.4 (4.9) 1.9 (2.5) 4.7 (2.0) 0.0 (6.1) 1.6 (7.3) 7.6 3.3 0.0 0.0
Other Non-Cash Items (1.1) (21.3) 16.5 2.3 0 0.0 34.7 0 0 1.9 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 (0.3) 0.1 0.0 (0.0)
Operating Cash Flow (22.3) (2.0) (17.5) (14.5) 29.0 (14.2) (13.7) 20.0 (10.5) (13.4) (13.4) (16.6) (25.2) (18.2) (19.9) (16.8) (20.8) (17.2) (20.7) (20.1) (22.7) (12.7) (10.5) (0.0) (0.0)
Investing Activities
Capital Expenditure (0.6) (0.1) 0 (0.4) (0.0) (0.0) (0.0) (0.0) 0 0 0 (0.3) (0.2) (0.5) (0.3) (0.8) (0.3) (0.4) (0.1) (0.4) (0.2) (0.1) (0.6) (0.0) (0.0)
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sales/Maturities of Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Investing Cash Flow (0.6) (0.1) 0 (0.4) (0.0) (0.0) (0.0) (0.0) 0 0 0 (0.3) (0.2) (0.5) (0.3) (0.8) (0.3) (0.4) (0.1) (0.4) (0.2) (0.1) (0.6) (0.0) (0.0)
Financing Activities
Net Debt Issuance 0 0 0 0 0 3.4 (0.0) (0.0) (3.4) (1.7) (2.2) (1.1) (1.7) (0.0) (0.0) (0.0) (0.0) 1.0 (0.7) (0.4) (0.0) (0.0) (0.1) 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (1.6) 0 0 0.0 0.0 4.8 0 17.5 0 0 0 0.1 0 0 0 0 0.0 (0.8) 0 0.0 0.0 0.2 0.0 0 0.0
Financing Cash Flow 35.7 35.9 (0.3) 47.4 4.8 8.2 (0.0) 20.0 1.0 (1.6) (2.2) (1.0) (1.7) (0.0) (0.0) (0.0) (0.0) 115.8 0.3 (0.3) 144.9 0.1 (0.1) 0 0.0
Cash Position
Net Change in Cash 12.8 33.8 (17.8) 32.5 33.8 (6.0) (13.7) 40.0 (9.5) (15.1) (15.6) (17.9) (27.1) (18.8) (20.3) (17.5) (21.1) 98.3 (20.5) (20.9) 122.0 (12.7) (11.1) (0.0) 0.0
Cash at Beginning 137.5 105.6 121.6 90.9 57.1 63.0 76.7 36.7 46.3 59.8 75.4 94.8 121.9 140.7 161.0 178.5 199.6 99.8 120.3 142.8 20.8 33.5 44.6 0.1 0.0
Cash at End 150.3 139.3 103.8 123.3 90.9 57.1 63.0 76.7 36.7 44.7 59.8 77.0 94.8 121.9 140.7 161.0 178.5 198.1 99.8 121.9 142.8 20.8 33.5 0.0 0.1
Free Cash Flow (22.9) (2.1) (17.5) (14.9) 29.0 (14.2) (13.7) 19.9 (10.5) (13.4) (13.4) (16.9) (25.4) (18.7) (20.2) (17.5) (21.1) (17.5) (20.8) (20.6) (22.9) (12.8) (11.0) (0.0) (0.0)
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Income Statement
Revenue 12.6 13.7 19.1 8.1 2.9 1.7 2.3 2.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 12.3 13.7 19.1 (7.2) 2.9 1.7 2.3 2.4 0 (0.4) 0 (0.5) 0 0 0 0 0 0 0 0 0 0 0 0 (0.1)
Operating Income (14.1) (11.8) (1.9) (14.4) (13.9) (13.6) (14.8) (14.7) (17.5) (18.1) (17.4) (20.1) (23.5) (23.2) (20.2) (24.6) (21.2) (19.6) (16.0) (23.0) (16.5) (20.6) (14.6) (11.4) (7.9)
Net Income (9.5) 10.4 (16.3) (15.8) (13.3) (13.1) (14.0) (13.9) (17.2) (17.7) (16.7) (19.4) (22.6) (22.5) (19.8) (24.6) (21.4) (19.7) (16.3) (23.2) (16.7) (20.8) (14.8) (11.5) (8.1)
EPS (Diluted) -0.58 0.81 -1.54 -4.34 -2.52 -2.80 -3.08 -4.48 -8.68 -8.96 -8.54 -9.80 -11.62 -11.48 -10.08 -12.60 -10.92 -13.72 -297.78 -440.72 -329.42 -440.44 -338.66 -391.72 -277.62
Balance Sheet
Cash & Equivalents 150.3 137.5 103.8 121.6 89.1 55.3 61.3 74.9 34.0 44.7 59.8 75.4 93.3 120.4 139.1 159.4 177.0 198.1 99.8 120.3 141.2 19.2
Total Assets 163.5 154.7 133.7 133.8 103.7 71.1 74.7 89.9 82.6 60.9 77.8 92.4 111.5 139.2 157.4 178.1 196.4 221.6 120.7 140.0 158.3 36.3
Total Debt 6.6 7.0 7.3 7.6 7.9 8.1 8.4 8.7 8.9 11.5 14.5 16.8 18.1 19.9 21.0 20.2 21.2 20.7 20.7 20.7 21.2 21.9
Stockholders' Equity 72.5 35.3 (8.1) 7.1 10.7 17.6 21.0 33.4 25.8 36.8 52.5 67.4 84.8 105.6 126.3 144.2 166.1 185.4 (136.5) 101.6 123.8 (5.3)
Cash Flow
Operating Cash Flow (22.3) (2.0) (17.5) (14.5) 29.0 (14.2) (13.7) 20.0 (10.5) (13.4) (13.4) (16.6) (25.2) (18.2) (19.9) (16.8) (20.8) (17.2) (20.7) (20.1) (22.7) (12.7) (10.5) (0.0) (0.0)
Capital Expenditure (0.6) (0.1) 0 (0.4) (0.0) (0.0) (0.0) (0.0) 0 0 0 (0.3) (0.2) (0.5) (0.3) (0.8) (0.3) (0.4) (0.1) (0.4) (0.2) (0.1) (0.6) (0.0) (0.0)
Free Cash Flow (22.9) (2.1) (17.5) (14.9) 29.0 (14.2) (13.7) 19.9 (10.5) (13.4) (13.4) (16.9) (25.4) (18.7) (20.2) (17.5) (21.1) (17.5) (20.8) (20.6) (22.9) (12.8) (11.0) (0.0) (0.0)